Paul Lehr
General Counsel bei LONGEVERON INC.
Vermögen: 20 741 $ am 30.04.2024
Aktive Positionen von Paul Lehr
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| LONGEVERON INC. | General Counsel | 01.01.2016 | - |
| Unternehmenssekretär | 01.01.2016 | - | |
| Groundupmusic | Direktor/Vorstandsmitglied | 01.01.2015 | - |
Heart Genomics LLC
 Heart Genomics LLC Miscellaneous Commercial ServicesCommercial Services Heart Genomics LLC is a biotechnology company that specializes in developing and commercializing non-invasive, genomic-based clinical diagnostic tests for patients with heart disease or heart failure. Heart Genomics is based in Miami Beach, FL. The private company's diagnostic tests provide personalized and individualized information to each patient and their physician through genomic analysis of the patient's heart tissue or blood sample. This information helps the heart patient and physician make substantially improved and clear treatment decisions. The company was founded by Paul Lehr and Joshua M. Hare, and Paul Lehr has been the CEO since incorporation. | Vorstandsvorsitzender | 01.01.2011 | - |
| Gründer | 01.01.2011 | - |
Karriereverlauf von Paul Lehr
Ausbildung von Paul Lehr
| Brown University | Undergraduate Degree |
| University of Florida Levin College of Law | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| General Counsel | 1 |
| Corporate Secretary | 1 |
| Director/Board Member | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LONGEVERON INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Groundupmusic | |
Heart Genomics LLC
Heart Genomics LLC Miscellaneous Commercial ServicesCommercial Services Heart Genomics LLC is a biotechnology company that specializes in developing and commercializing non-invasive, genomic-based clinical diagnostic tests for patients with heart disease or heart failure. Heart Genomics is based in Miami Beach, FL. The private company's diagnostic tests provide personalized and individualized information to each patient and their physician through genomic analysis of the patient's heart tissue or blood sample. This information helps the heart patient and physician make substantially improved and clear treatment decisions. The company was founded by Paul Lehr and Joshua M. Hare, and Paul Lehr has been the CEO since incorporation. | Commercial Services |
